Advertisement

Topics

Center for Lawful Access and Abuse Deterrence Company Profile

22:34 EST 14th December 2018 | BioPortfolio


News Articles [1185 Associated News Articles listed on BioPortfolio]

FDA Panels Nix Approval of Abuse-Deterrent Oxycodone for Pain

Two FDA advisory committees voted 14-3 against approval recommendation for Remoxy ER, voicing concerns over the product's claims of abuse deterrence via various routes. Medscape Medical News

Mallinckrodt's Abuse-Deterrent Oxycodone IR May Face Hurdle At US FDA Panel

FDA finds no benefit in deterring intranasal abuse; final data not yet submitted to determine IV abuse deterrence.   

US FDA Launches Study Of Prescriber Perceptions About Abuse-Deterrent Opioids

The agency is assessing whether to use different language to describe addiction and abuse deterrence.   

PTI's Remoxy: US FDA Panel To Weigh Intranasal Abuse Deterrence Against Oral Abuse Potential

Agency reviewers see lower potential for intranasal abuse with Pain Therapeutics' extended-release opioid compared to immediate-release oxycodone, but an increased...   

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s efforts to encourage the development of and broaden access to generic versions of opioid analgesics that are formulated to deter abuse

FDA posted a new batch of 43 product-specific guidances related to the development of generic drug products that includes three revised product-specific guidances for ADF opioid products. These guidan...

Does Sale Of Confidential Invention Prevent Its Patenting? US Supreme Court Will Review

Helsinn v. Teva challenges whether inventor's sale of an invention to a third party that must in turn keep the...   

The Quality Lowdown: ICH Q13 and Q14, Gene Therapy CMC, Drug Shortage Gaps, And An Excipient Misstep

ICH launches continuous manufacturing and analytical procedure guidelines while US FDA promises advice on gene therapy CMC, battles drug shortages...   

5 Signs You Need to Go to Recovery Center

Getting to identify a drug abuse case and determining whether it is appropriate to join a rehab center is not as easy. Mostly, physical signs... Read More →

Drugs and Medications [76 Associated Drugs and Medications listed on BioPortfolio]

Formucare triple antibiotic [Access Business Group International LLC]

Access Business Group International LLC Triple Antibiotic Drug Facts

Fulton street market athletes foot [Access Business Group LLC]

Access Business Group LLC Athlete's Foot Cream Drug Facts

Formucare ranitidine [Access Business Group International LLC]

Access Business Group International LLC Ranitidine 75 Drug Facts

Glister multi-action fluoride toothpaste [Access Business Group, LLC]

Glister Multi-action Fluoride Toothpaste

Formucare athletes foot [Access Business Group International LLC]

Access Business Group International LLC Athlete's Foot Powder Spray Drug Facts

PubMed Articles [1739 Associated PubMed Articles listed on BioPortfolio]

Access Delayed is Access Denied: Relationship between Access to Trauma Center Care and Pre-Hospital Death.

Timely access to trauma center(TC) care is critical to achieve "Zero Preventable Deaths After Injury." However, the impact of timely access to TC care on pre-hospital deaths in each US state remains u...

Methodological approaches to the analyses of elder abuse screening measures: Application of latent variable measurement modeling to the WC-RAPS.

While several elder abuse screens exist, few measure risk and none target long-term support services. The aims were to examine the psychometric properties of the Weinberg Center Risk and Abuse Prevent...

Motives of abuse of psychoactive substances by women assisted in a Psychosocial Attention Center.

To understand the reasons attributed by women to the abuse of psychoactive substances.

How do you recognise sexual abuse in children?

One in three children will experience sexual violence before they are 18 years old. The recognition and evaluation of alleged child sexual abuse is complex. Presently there are no validated, self-cont...

A Multipronged Initiative to Improve Productivity and Patient Access in a Federally Qualified Health Center Network.

In 2012, Access Community Health Network, a Federally Qualified Health Center (FQHC) network with 36 health centers serving the greater Chicago area, embarked on a 3-year initiative to improve patient...

Clinical Trials [4043 Associated Clinical Trials listed on BioPortfolio]

Feasibility of a Smart-phone Based Support System for Hazardous Drinkers

A feasibility trial to determine whether six months access to the New Zealand 'Step Away' app can reduce the frequency of alcohol abuse and increase engagement with substance abuse-related...

Telephone Intervention to Increase Safety in Abused Women

Although abuse by an intimate partner is very common and has serious negative effects on women's health, few studies have been done to test ways to increase safety for women in abusive rel...

Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse

The purpose of this study is to determine the relative abuse potential of ramelteon, once daily (QD), compared to triazolam in subjects with a history of drug abuse.

Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse

The purpose of this study is: (1) to assess the effect of oxycodone HCl on niacin-induced dysphoric effects when oxycodone HCl is administered in combination with niacin in subjects with a...

Exploration of the Potential Role of Brain Magnetic Stimulation in Preventing Relapse to Alcohol Abuse

dTMS intervention to reduce recurrent alcohol abuse among alcohol users who are abstinent for at least two weeks.

Companies [2397 Associated Companies listed on BioPortfolio]

Center for Lawful Access and Abuse Deterrence

Tris Pharma

Tris Pharma is a product-focused, specialty pharmaceutical company engaged in the research and development of innovative drug delivery technologies. Through its OralXR+ platform, Tris has pioneered th...

Prescription Drug Research Center

The Prescription Drug Research Center is located at the Mason Enterprise Center, a part of George Mason University, in Fairfax, Virginia. As a member of the Mason Enterprise Center, PDRC enjoys access...

Didi Hirsch Mental Health Services

With almost 70 years of experience, Didi Hirsch provides mental health and substance abuse services at ten sites in Los Angeles and Orange County. A member of the National Suicide...

Gatekeeper Innovation, Inc.

Gatekeeper Innovation saves lives endangered by prescription drug abuse. The company makes affordable products that reduce prescription abuse potential and, in doing so, ch...

More Information about "Center for Lawful Access and Abuse Deterrence" on BioPortfolio

We have published hundreds of Center for Lawful Access and Abuse Deterrence news stories on BioPortfolio along with dozens of Center for Lawful Access and Abuse Deterrence Clinical Trials and PubMed Articles about Center for Lawful Access and Abuse Deterrence for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Center for Lawful Access and Abuse Deterrence Companies in our database. You can also find out about relevant Center for Lawful Access and Abuse Deterrence Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record